Summit Therapeutics Options Trading: A Deep Dive into Market Sentiment
Portfolio Pulse from Benzinga Insights
Summit Therapeutics (NASDAQ:SMMT) has seen significant options trading activity, with a mix of bullish and bearish sentiment. The stock is currently trading at $23.4, with analysts setting price targets between $16 and $25. The options market suggests a potential price range of $14 to $30.
September 11, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Summit Therapeutics has experienced notable options trading activity, indicating mixed market sentiment. The stock is currently priced at $23.4, with analysts' price targets ranging from $16 to $25. Options suggest a potential price range of $14 to $30.
The options trading activity for Summit Therapeutics shows a balanced sentiment with both bullish and bearish trades. The current stock price is $23.4, and analysts have set varied price targets. The options market suggests a wide potential price range, indicating uncertainty in short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100